Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
StockCIK 1551306

Progyny, Inc. (PGNY): Insider Trades and Fund Holdings

In the past 12 months, Progyny, Inc. insiders reported 0 open-market purchases worth $0 and 3 sales worth $476K; 2 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months
$0Bought by insiders, 12 months
$476KSold by insiders, 12 months
2Tracked funds holding

Timeline: news and trades

Company filings (8-K), insider trades, notices of planned sales (Form 144) and fund moves in the past year, newest first.

  1. Oct 14, 2026Insider saleCOO Melissa B. Cummings sold $52,612 under a 10b5-1 plan
  2. Oct 14, 2026Planned saleCummings Melissa B (officer) filed notice to sell about $52,612 around Oct 14, 2026
  3. Sep 23, 2026Insider saleEVP Allison Swartz sold $101,868 under a 10b5-1 plan
  4. Sep 23, 2026Planned saleSwartz Allison (officer) filed notice to sell about $101,868 around Sep 23, 2026
  5. Sep 10, 2026Insider saleDirector Kevin K. Gordon sold $321,358
  6. Sep 10, 2026Planned saleGORDON KEVIN K (director) filed notice to sell about $311,859 around Sep 10, 2026
  7. Jun 30, 2026FundBridgewater Associates opened a position in Q2 2026 (13F filed Aug 14, 2026)
  8. Jun 30, 2026FundRenaissance Technologies cut 48% in Q2 2026 (13F filed Aug 13, 2026)

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 16, 2026.

Recent PGNY insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHoldingFiling
Oct 16Oct 14Melissa B. CummingsCOOCOO▼ SELL10b5-11,87928.00$53K−2.7%Form 4 ↗
Sep 28Sep 23Allison SwartzEVPEVP▼ SELL10b5-13,90326.10$102K−4.9%Form 4 ↗
Sep 14Sep 10Kevin K. GordonDirectorDirector▼ SELL11,50027.94$321K−63%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Melissa B. CummingsCOO0$01$53KOct 16, 2026
Allison SwartzEVP0$01$102KSep 28, 2026
Kevin K. GordonDirector0$01$321KSep 14, 2026

Buybacks and executive pay

Progyny, Inc. spent $81.7 million buying back its own shares in 2025.

YearCEO pay reportedCEO pay "actually paid"Value of $100 invested
2025$7.22M$10.3Mn/a
2024$1.36M−$16.0Mn/a
2023$1.09M$7.27Mn/a

From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.

Tracked funds that report PGNY

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

FundQuarterSharesValue% of portfolioChange
Renaissance TechnologiesQ2 2026424,667$12.2M0.02%▼ −47.7%
Bridgewater AssociatesQ2 202651,738$1.49M0.01%▲ New
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →